LXRβ-Selective Agonism Enhances CYP2J2-Mediated DHA Epoxide Generation to Restore Synaptic Membrane Homeostasis in Alzheimer's Disease
🧪 Overview
This hypothesis proposes that LXRβ-selective agonists enhance CYP2J2 expression and activity to increase protective DHA epoxide generation, simultaneously addressing both cholesterol dysregulation and membrane rigidification in Alzheimer's disease. LXR signaling is known to upregulate cytochrome P450 enzymes involved in lipid metabolism, including CYP2J2, through direct transcriptional control. By selectively activating LXRβ, this approach would increase endogenous CYP2J2-mediated conversion of DHA to protective epoxides that prevent Aβ-induced synaptic membrane rigidification, while concurrently promoting cholesterol efflux from activated microglia and enhancing APOE lipidation. This dual mechanism addresses the critical pathophysiology where Aβ oligomers increase membrane cholesterol content by ~40% and expand raft domains in cortical neurons. The LXRβ-mediated upregulation of CYP2J2 would provide a sustainable source of protective epoxides, potentially overcoming the pharmacokinetic limitations of direct DHA supplementation where epoxides have 2-4 hour half-lives due to rapid sEH metabolism.
...🧬 Mechanism
Curated pathway from expert analysis
flowchart TD
A["DHA Substrate Pool<br/>Membrane Omega-3 Lipids"]
B["CYP2J2 Epoxygenase<br/>DHA-to-Epoxide Conversion"]
C["Epoxy-DHA Mediators<br/>Anti-inflammatory Lipid Signals"]
D["sEH Inhibition<br/>Epoxide Lifetime Prolonged"]
E["Synaptic Membrane Fluidity<br/>A-beta-Induced Rigidification Blocked"]
F["Excitatory Signaling Stability<br/>Receptor Mobility Preserved"]
G["Synaptic Protection<br/>Reduced A-beta Toxicity"]
A --> B
B --> C
D --> C
C --> E
E --> F
F --> G
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style D fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style G fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — NR1H2
No curated PDB or AlphaFold mapping for NR1H2 yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for NR1H2 (LXRβ).
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |